MedPage Today The Vaccine Integrity Project is analyzing the latest data. This fall, millions of Americans will decide whether to get themselves and their families immunized against flu, COVID-19, and respiratory syncytial virus (RSV). These are not small choices: immunizations save lives, prevent hospitalizations, and protect the most vulnerable among us, and — very rarely — result in adverse events.
But as recommendations shift and federal guidance changes, clinicians and families alike are asking: Who can we trust? That question is at the heart of the Vaccine Integrity Project, an initiative of the University of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP). The Vaccine Integrity Project is supported by an unrestricted gift from Alumbra Innovations Foundation, established by philanthropist Christy Walton. With feedback from over 60 organizations, the Vaccine Integrity Project aims to safeguard vaccine use in the U.S. by ensuring it remains rooted in the best available science, free from external influence, and focused on safely optimizing protection of individuals, families, and communities against vaccine-preventable diseases.